Improving the outcome of adoptive cell transfer by targeting tumor escape

Adoptive T-cell transfer is among the most promising immunotherapies against cancer. To continue increasing the potential of this therapy, our studies focus on the inhibition of tumor recurrence. Recently, we have demonstrated several ways in which combination therapies involving multiple T-cell pop...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaluza, Karen M., Vile, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583906/
https://www.ncbi.nlm.nih.gov/pubmed/23483796
http://dx.doi.org/10.4161/onci.22059
_version_ 1782475503503933440
author Kaluza, Karen M.
Vile, Richard
author_facet Kaluza, Karen M.
Vile, Richard
author_sort Kaluza, Karen M.
collection PubMed
description Adoptive T-cell transfer is among the most promising immunotherapies against cancer. To continue increasing the potential of this therapy, our studies focus on the inhibition of tumor recurrence. Recently, we have demonstrated several ways in which combination therapies involving multiple T-cell populations and immunostimulatory chemotherapy can enhance long-term survival.
format Online
Article
Text
id pubmed-3583906
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-35839062013-03-11 Improving the outcome of adoptive cell transfer by targeting tumor escape Kaluza, Karen M. Vile, Richard Oncoimmunology Author's View Adoptive T-cell transfer is among the most promising immunotherapies against cancer. To continue increasing the potential of this therapy, our studies focus on the inhibition of tumor recurrence. Recently, we have demonstrated several ways in which combination therapies involving multiple T-cell populations and immunostimulatory chemotherapy can enhance long-term survival. Landes Bioscience 2013-01-01 /pmc/articles/PMC3583906/ /pubmed/23483796 http://dx.doi.org/10.4161/onci.22059 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Kaluza, Karen M.
Vile, Richard
Improving the outcome of adoptive cell transfer by targeting tumor escape
title Improving the outcome of adoptive cell transfer by targeting tumor escape
title_full Improving the outcome of adoptive cell transfer by targeting tumor escape
title_fullStr Improving the outcome of adoptive cell transfer by targeting tumor escape
title_full_unstemmed Improving the outcome of adoptive cell transfer by targeting tumor escape
title_short Improving the outcome of adoptive cell transfer by targeting tumor escape
title_sort improving the outcome of adoptive cell transfer by targeting tumor escape
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583906/
https://www.ncbi.nlm.nih.gov/pubmed/23483796
http://dx.doi.org/10.4161/onci.22059
work_keys_str_mv AT kaluzakarenm improvingtheoutcomeofadoptivecelltransferbytargetingtumorescape
AT vilerichard improvingtheoutcomeofadoptivecelltransferbytargetingtumorescape

Ejemplares similares